Gainers
- Versus Systems Inc. (NASDAQ:VS) rose 66% to $0.7802 in pre-market trading. Versus Systems, last month, received NASDAQ notification regarding minimum bid price deficiency.
- Histogen Inc.. (NASDAQ:HSTO) rose 47.4% to $4.35 in pre-market trading after gaining around 12% on Monday. The company, last month, announced a 1-for-20 reverse stock split.
- First Wave BioPharma, Inc. (NASDAQ:FWBI) rose 23.8% to $0.26 in pre-market trading after declining over 16% on Monday.
- Novo Integrated Sciences, Inc. (NASDAQ:NVOS) rose 21.2% to $2.29 in pre-market trading. The company said it sees Q3 preliminary unaudited revenue to be in the range of $13.4 million to $13.9 million, a surge of around 463% to 484% year-over-year.
- TherapeuticsMD, Inc. (NASDAQ:TXMD) rose 13.4% to $8.63 in pre-market trading after dipping around 20% on Monday. EW Healthcare Partners recently announced extension of TherapeuticsMD tender offer.
- Lion Group Holding Ltd. (NASDAQ:LGHL) rose 12.9% to $1.49 in pre-market trading.
- AIM ImmunoTech Inc. (NYSE:AIM) rose 12.6% to $0.89 in pre-market trading.
- T2 Biosystems, Inc. (NASDAQ:TTOO) rose 12.4% to $0.1716 in pre-market trading. The U.S. Food and Drug Administration, on Monday, granted Breakthrough Device Designation for T2 Biosystems’ T2Lyme Panel, intended to test individuals with signs and symptoms of Lyme disease and aid in the diagnosis of early Lyme disease.
- Redbox Entertainment Inc. (NASDAQ:RDBX) rose 10.9% to $6.39 in pre-market trading after declining 7% on Monday.
- Westport Fuel Systems Inc. (NASDAQ:WPRT) rose 10.9% to $1.12 in pre-market trading. Westport Fuel Systems was awarded €38 million program to supply LPG fuel systems to a global OEM.
- AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) rose 10.2% to $0.3196 in pre-market trading after declining around 5% on Monday.
- Tiziana Life Sciences Ltd (NASDAQ:TLSA) rose 9.5% to $0.91 in pre-market trading.
- Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) rose 8.7% to $3.25 in pre-market trading after declining 7% on Monday.
- IceCure Medical Ltd (NASDAQ:ICCM) rose 8.1% to $1.86 in pre-market trading.
